Publications

Journal articles, conference papers, and preprints. Formal DOI, PubMed, arXiv, or project links are used when verified.

Journals

2026
Spontaneous dynamic gene expression of Schlafen 11 (SLFN11) demonstrated by single-cell RNA sequencing in clonal cancer cell lines
Taniyama, D., Inoue, Y., et al.
Oncogene (submitted).
2026
DrugAgent: Reliable Multi-Agent Aggregation under Conflicting Biomedical Evidence
Inoue, Y., Song, T., Wang, X., Luna, A., & Fu, T.
Scientific Reports (under revision).
Code Related OpenReview paper
2026
Drug Discovery in the Era of Artificial Intelligence: From Target Identification to Clinical Trials
Inoue, Y., Hao, N., Lu, Y., Fu, T., & Luna, A.
Health Data Science (accepted).
2026
TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies
Hoshi-Kadonosawa, Y., Reinhold, W. C., Taniyama, D., Inoue, Y., et al.
Molecular Cancer Therapeutics.
DOI PubMed
2026
drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph
Inoue, Y., Lee, H., Fu, T., Kuang, R., & Luna, A.
BMC Bioinformatics.
DOI Code PubMed
2026
CellMiner cross-database (CellMinerCDB) version 2.2 for explorations of patient-derived cancer cell line pharmacogenomics
Elloumi, F., Reinhold, W. C., Varma, S., et al., Inoue, Y., et al.
Nucleic Acids Research.
DOI PubMed

2026
DrugAgent: Reliable Multi-Agent Aggregation under Conflicting Biomedical Evidence
ICML 2026 Workshop on FM4LS.
Code
2025
GraphPINE: Graph Importance Propagation for Interpretable Drug Response Prediction
ICLR 2025 Workshop on MLGenX · arXiv:2504.05454.
arXiv Code PubMed
2025
DrugAgent: Explainable Drug Repurposing Agent with Large Language Model-based Reasoning
ICLR 2025 Workshop on MLGenX.
arXiv Code
2024
BiGCN: Leveraging Cell and Gene Similarities for Single-cell Transcriptome Imputation with Bi-Graph Convolutional Networks
Inoue, Y., Kulman, E., & Kuang, R.
bioRxiv.